BioCentury | Dec 4, 2006
Strategy

Crucell chronicles

...valued at CHF591M ($448.1M) P. 3/27/06 - Says it will sell biopharmaceutical and vaccine manufacturer Rhein Biotech...
BioCentury | May 1, 2006
Company News

Crucell N.V, Dynavax deal

...DVAX completed its previously announced acquisition of CRXL's Rhein Biotech GmbH subsidiary (Duesseldorf, Germany) for $12 million...
BioCentury | Apr 3, 2006
Company News

Crucell, Dynavax deal

...DVAX will acquire CRXL's Rhein Biotech GmbH subsidiary (Duesseldorf, Germany) for $12 million in cash. Rhein produces...
BioCentury | Dec 5, 2005
Strategy

Infectious ambition

...in the portfolio is Hepavax-Gene , a recombinant vaccine against hepatitis B, originally developed by Rhein Biotech...
BioCentury | Nov 9, 2005
Company News

Hybrigenics names Delansorne CEO

...also appointed Daan Ellens as chairman. Ellens is a director of Zealand Pharma (Glostrup, Denmark), Rhein Biotech...
BioCentury | May 30, 2005
Company News

Berna infectious, drug delivery news

...Vaccine company BBIN plans to spin out its Rhein Biotech GmbH subsidiary (Duesseldorf, Germany), which it acquired...
BioCentury | May 16, 2005
Company News

Berna management update

...Ltd. (SWX:BBIN), Berne, Switzerland Business: Infectious, Drug delivery Transition: Daan Ellens to chairman of BBIN's Rhein Biotech...
BioCentury | Mar 28, 2005
Company News

Berna, Mega Pharma S.A. deal

...BV generics unit (Buenos Aires, Argentina) for an undisclosed sum. The unit is part of Rhein Biotech N.V....
BioCentury | Jun 21, 2004
Finance

Ebb & Flow

...down from his current post as COO of Berna Biotech (SWX:BBIN). Ellens was CEO of Rhein Biotech...
BioCentury | Jun 15, 2004
Financial News

Ellens joins Life Sciences Partners

...Daan Ellens joined Life Sciences Partners as a partner. Ellens was the CEO of Rhein Biotech until...
Items per page:
1 - 10 of 100
BioCentury | Dec 4, 2006
Strategy

Crucell chronicles

...valued at CHF591M ($448.1M) P. 3/27/06 - Says it will sell biopharmaceutical and vaccine manufacturer Rhein Biotech...
BioCentury | May 1, 2006
Company News

Crucell N.V, Dynavax deal

...DVAX completed its previously announced acquisition of CRXL's Rhein Biotech GmbH subsidiary (Duesseldorf, Germany) for $12 million...
BioCentury | Apr 3, 2006
Company News

Crucell, Dynavax deal

...DVAX will acquire CRXL's Rhein Biotech GmbH subsidiary (Duesseldorf, Germany) for $12 million in cash. Rhein produces...
BioCentury | Dec 5, 2005
Strategy

Infectious ambition

...in the portfolio is Hepavax-Gene , a recombinant vaccine against hepatitis B, originally developed by Rhein Biotech...
BioCentury | Nov 9, 2005
Company News

Hybrigenics names Delansorne CEO

...also appointed Daan Ellens as chairman. Ellens is a director of Zealand Pharma (Glostrup, Denmark), Rhein Biotech...
BioCentury | May 30, 2005
Company News

Berna infectious, drug delivery news

...Vaccine company BBIN plans to spin out its Rhein Biotech GmbH subsidiary (Duesseldorf, Germany), which it acquired...
BioCentury | May 16, 2005
Company News

Berna management update

...Ltd. (SWX:BBIN), Berne, Switzerland Business: Infectious, Drug delivery Transition: Daan Ellens to chairman of BBIN's Rhein Biotech...
BioCentury | Mar 28, 2005
Company News

Berna, Mega Pharma S.A. deal

...BV generics unit (Buenos Aires, Argentina) for an undisclosed sum. The unit is part of Rhein Biotech N.V....
BioCentury | Jun 21, 2004
Finance

Ebb & Flow

...down from his current post as COO of Berna Biotech (SWX:BBIN). Ellens was CEO of Rhein Biotech...
BioCentury | Jun 15, 2004
Financial News

Ellens joins Life Sciences Partners

...Daan Ellens joined Life Sciences Partners as a partner. Ellens was the CEO of Rhein Biotech until...
Items per page:
1 - 10 of 100